Use of serotonergic antidepressants and bleeding risk in patients undergoing surgery

Psychosomatics

Volumn 55, Issue 3, 2014, Pages 213-220

  Jeong, Bo Ok ^a   Kim, Sung Wan ^a   Kim, Seon Young ^a   Kim, Jae Min ^a   Shin, Il Seon ^a   Yoon, Jin Sang ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; MIRTAZAPINE; TRAZODONE; VENLAFAXINE; SEROTONIN UPTAKE INHIBITOR;

BLEEDING; BLOOD TRANSFUSION; BREAST SURGERY; CORONARY ARTERY BYPASS GRAFT; FACE SURGERY; HUMAN; ORTHOPEDIC SURGERY; PERIOPERATIVE BLEEDING; PERIOPERATIVE PERIOD; PEROPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; REOPERATION; REVIEW; SURGICAL PATIENT; BLOOD LOSS, SURGICAL; CHEMICALLY INDUCED; DEPRESSIVE DISORDER; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ANTIDEPRESSIVE AGENTS; BLOOD LOSS, SURGICAL; DEPRESSIVE DISORDER; HUMANS; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS;

EID: 84899650141     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2013.08.011     Document Type: Review

References (50)

1. Cheeta S., Schifano F., Oyefeso A., Webb L., Ghodse A.H. Antidepressant-related deaths and antidepressant prescriptions in England and Wales, 1998-2000. Br J Psychiatry 2004, 184:41-47.
2. Mourilhe P., Stokes P.E. Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression. Drug Saf 1998, 18:57-82.
3. Spigset O. Adverse reactions of selective serotonin reuptake inhibitors: reports from a spontaneous reporting system. Drug Saf 1999, 20:277-287.
4. Ferguson J.M. SSRI antidepressant medications: adverse effects and tolerability. Prim Care Companion J Clin Psychiatry 2001, 3:22-27.
5. Looper K.J. Potential medical and surgical complications of serotonergic antidepressant medications. Psychosomatics 2007, 48:1-9.
6. Andrade C., Sandarsh S., Chethan K.B., Nagesh K.S. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms. J Clin Psychiatry 2010, 71:1565-1575.
7. Yamamoto T., Abe K., Hattori K., Ishii T., Kuyama Y. High prevalence of gastroduodenal mucosal injury in patients taking selective serotonin reuptake inhibitors. Dig Endosc 2010, 22:77.
8. Coupland C., Dhiman P., Morriss R., Arthur A., Barton G., Hippisley-Cox J. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. Br Med J 2011, 343:d4551.
9. Labos C., Dasgupta K., Nedjar H., Turecki G., Rahme E. Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction. CMAJ 2011, 183:1835-1843.
10. Mortensen J.K., Larsson H., Johnsen S.P., Andersen G. Post stroke use of selective serotonin reuptake inhibitors and clinical outcome among patients with ischemic stroke: a nationwide propensity score-matched follow-up study. Stroke 2013, 44:420-426.
11. Hackam D.G., Mrkobrada M. Selective serotonin reuptake inhibitors and brain hemorrhage: a meta-analysis. Neurology 2012, 79:1862-1865.
12. Meier C.R., Schlienger R.G., Jick H. Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction. Br J Clin Pharmacol 2001, 52:179-184.
13. Kharofa J., Sekar P., Haverbusch M., et al. Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Stroke 2007, 38:3049-3051.
14. Salkeld E., Ferris L.E., Juurlink D.N. The risk of postpartum hemorrhage with selective serotonin reuptake inhibitors and other antidepressants. J Clin Psychopharmacol 2008, 28:230-234.
15. Napenas J.J., Hong C.H., Kempter E., Brennan M.T., Furney S.L., Lockhart P.B. Selective serotonin reuptake inhibitors and oral bleeding complications after invasive dental treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011, 112:463-467.
16. Meijer W.E., Heerdink E.R., Nolen W.A., Herings R.M., Leufkens H.G., Egberts A.C. Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med 2004, 164:2367-2370.
17. de Abajo F.J. Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients. Drugs Aging 2011, 28:345-367.
18. Hougardy D.M., Egberts T.C., van der Graaf F., Brenninkmeijer V.J., Derijks L.J. Serotonin transporter polymorphism and bleeding time during SSRI therapy. Br J Clin Pharmacol 2008, 65:761-766.
19. Abdelmalik N., Ruhe H.G., Barwari K., van den Dool E.J., Meijers J.C., Middeldorp S., et al. Effect of the selective serotonin reuptake inhibitor paroxetine on platelet function is modified by a SLC6A4 serotonin transporter polymorphism. J Thromb Haemost 2008, 6:2168-2174.
20. McCloskey D.J., Postolache T.T., Vittone B.J., et al. Selective serotonin reuptake inhibitors: measurement of effect on platelet function. Transl Res 2008, 151:168-172.
21. Serebruany V.L. Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something?. Am J Med 2006, 119:113-116.
22. Movig K.L., Janssen M.W., de Waal Malefijt J., Kabel P.J., Leufkens H.G., Egberts A.C. Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients. Arch Intern Med 2003, 163:2354-2358.
23. van Haelst I.M., Egberts T.C., Doodeman H.J., et al. Use of serotonergic antidepressants and bleeding risk in orthopedic patients. Anesthesiology 2010, 112:631-636.
24. Sayadipour A., Mago R., Kepler C.K., et al. Antidepressant and the risk of abnormal bleeding during spinal surgery: a case-control study. Eur Spine J 2012, 21:2070-2078.
25. Sinikallio S., Aalto T., Airaksinen O., Lehto S.M., Kroger H., Viinamaki H. Depression is associated with a poorer outcome of lumbar spinal stenosis surgery: a two-year prospective follow-up study. Spine 2011, 36:677-682.
26. Gartner R., Cronin-Fenton D., Hundborg H.H., et al. Use of selective serotonin reuptake inhibitors and risk of re-operation due to post-surgical bleeding in breast cancer patients: a Danish population-based cohort study. BMC Surg 2010, 10:3.
27. Basile F.V., Basile A.R., Basile V.V. Use of selective reuptake inhibitors antidepressants and bleeding risk in breast cosmetic surgery. Aesthetic Plast Surg 2013, 37:561-566.
28. Xiong G.L., Jiang W., Clare R., et al. Prognosis of patients taking selective serotonin reuptake inhibitors before coronary artery bypass grafting. Am J Cardiol 2006, 98:42-47.
29. Tibold A., Feher G., Csejtei A., Tettinger A., Kiss I. Selective serotonin reuptake inhibitors may interfere with the antiplatelet effect of clopidogrel. Am J Cardiol 2007, 99:1025-1026.
30. Xiong G.L., Jiang W., Clare R.M., et al. Safety of selective serotonin reuptake inhibitor use prior to coronary artery bypass grafting. Clin Cardiol 2010, 33:E94-E98.
31. Harirchian S., Zoumalan R.A., Rosenberg D.B. Antidepressants and bleeding risk after face-lift surgery. Arch Facial Plast Surg 2012, 14:248-252.
32. Andreasen J.J., Riis A., Hjortdal V.E., Jorgensen J., Sorensen H.T., Johnson S.P. Effect of selective serotonin reuptake inhibitors on requirement for allogenic red blood cell transfusion following coronary artery bypass surgery. Am J Cardiovasc Drugs 2006, 6:243-250.
33. Kim D.H., Daskalakis C., Whellan D.J., et al. Safety of selective serotonin reuptake inhibitor in adults undergoing coronary artery bypass grafting. Am J Cardiol 2009, 103:1391-1395.
34. Tully P.J., Cardinal T., Bennetts J.S., Baker R.A. Selective serotonin reuptake inhibitors, venlafaxine and duloxetine are associated with in hospital morbidity but not bleeding or late mortality after coronary artery bypass surgery. Heart Lung Circ 2012, 21:206-214.
35. Cozza K.L., Wynn G.H. SRIs and bleeding; transporters; metformin and olanzapine. Psychosomatics 2011, 52:589-592.
36. Merriman E., Tran H. Antiplatelet drugs, anticoagulants and elective surgery. Aust Prescr 2011, 34:139-143.
37. Januzzi J.L., Stern T.A., Pasternak R.C., DeSanctis R.W. The influence of anxiety and depression on outcomes of patients with coronary artery disease. Arch Intern Med 2000, 160:1913-1921.
38. Kim S.Y., Kim J.M., Kim S.W., et al. Associations between plasma cytokines and depressive mood in patients with breast cancer. Int J Psychiatry Med 2012, 43:1-17.
39. Favaro A., Gerosa G., Caforio A.L., et al. Posttraumatic stress disorders and depression in heart transplantation recipients: the relationship with outcome and adherence to medical treatment. Gen Hosp Psychiatry 2011, 33:1-7.
40. Valuck R.J., Orton H.D., Libby A.M. Antidepressant discontinuation and risk of suicide attempt: a retrospective, nested case-control study. J Clin Psychiatry 2009, 70:1069-1077.
41. Michelson D., Fava M., Amsterdam J., et al. Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo-controlled trial. Br J Psychiatry 2000, 176:363-368.
42. Fava M. Prospective studies of adverse events related to antidepressant discontinuation. J Clin Psychiatry 2006, 67:14-21.
43. Mansour A., Pearce M., Johnson B., et al. Which patients taking SSRIs are at greatest risk of bleeding?. J Fam Pract 2006, 55:206-208.
44. Croom K.F., Perry C.M., Plosker G.L. Mirtazapine: a review of its use in major depression and other psychiatric disorders. CNS Drugs 2009, 23:427-452.
45. Athimulam S, Sharma N, Khan SA: Uppergastrointestinal bleeding in a patient receiving selective serotonin reuptake inhibitor. BMJ Case Rep 2011; 10.1136/bcr.01.2011.3741.
46. Renoir T. Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved. Front Pharmacol 2013, 4:45.
47. Humphries J.E., Wheby M.S., VandenBerg S.R. Fluoxetine and the bleeding time. Arch Pathol Lab Med 1990, 114:727-728.
48. Shelton R.C. Steps following attainment of remission: discontinuation of antidepressant therapy. Prim Care Companion J Clin Pschiatry 2001, 3:168-174.
49. Warner C.H., Bobo W., Warner C., Reid S., Rachal J. Antidepressant discontinuation syndrome. Am Fam Physician 2006, 74:449-456.
50. Schatzberg A.F., Clier P., Delgado P.L., Fava M., Haddad P.M., Shelton R.C. Antidepressant discontinuation syndrome: consensus panel recommendations for clinical management and additional research. J Clin Psychiatry 2006, 67:27-30.